Global Pigmentation Disorders Treatment Industry | Market Research Report, Popular Trends & Technological Advancements, Forecast & Opportunities

Uncategorized

Source: honestversion.com

The Pigmentation Disorders Treatment Market’s segment market shares in each geographic region are mentioned in the report, along with the historic and forecast growth rates. Each segment represented visually with supporting reasons to justify the growth rates. IGR’s report also covers drivers and restraints in the pigmentation disorders treatment market.

Infinium Global Research’s report covers the annual growth of the Global pigmentation disorders treatment market. It also includes chapters on the Global pigmentation disorders treatment industry trends, geographic analysis, and competitive landscape.

The report also includes a SWOT analysis to present the indicators of strength, weakness, prospects, and risk of the market until the completion of the projection period in 2024.

The global pigmentation disorders treatment market is projected to grow at a CAGR of 5.9% over the forecast period of 2018-2024.

Pigmentation Disorders Treatment Market: Industry Insights

Pigmentation disorders are a group of disease that is caused as the level of the pigment melanin changes.  The pigment melanin is produced by melanocytes, the cells that are manufacture pigment in the skin or it can be produced owing to the accumulation of other pigments in the skin.

Pigmentation Disorders Treatment Market: Drivers and Restraints

The rising prevalence of skin disorders, as well as increased incidence of skin disorders in children, drives the growth pigmentation disorder treatment market. Furthermore, changing lifestyle and increasing awareness of people towards the improvement in the affected skin fuel the growth of pigmentation disorders treatment market. However, the high cost required for the therapy that may hamper the growth of pigmentation disorders treatment market. Growing advancement in cosmetic therapy and surgery provides beneficial opportunities for pigmentation disorders treatment market.

Pigmentation Disorders Treatment Market: Segmentation

Pigmentation disorders treatment market is segmented into Treatment & Therapies type, Disease Indication type, and End-user. Among these types Treatment & Therapies is categorized into chemical peels, dermabrasion, laser resurfacing, melasma and several other therapies are included. Among these types, dermabrasion is a curative treatment for melasma. Laser resurfacing treatment minimize wrinkles, scars, and blemishes as well as laser skin resurfacing used to remove skin layer by layer with precision.

By disease indication, pigmentation disorders treatment market is segmented into hypopigmentation and hyperpigmentation. Hyperpigmentation darkens the skin, while hypopigmentation also known as skin depigmentation that refers to the lightening of the skin. By End-user pigmentation disorders treatment market is categorized into dermatology clinics, hospitals, and some other end users.

Pigmentation Disorders Treatment Market: Regional Insights

Geographically, pigmentation disorders treatment market is divided into North America, Europe, Asia Pacific, and ROW. The Asia Pacific dominated the pigmentation disorders treatment market. The increasing growth of pigmentation disorders treatment in the Asia Pacific is owing to rising population in the region. Furthermore, in North America, the demand for pigmentation disorder treatment is rapidly growing that in turn fuels the growth of pigmentation disorders treatment market in the region. The Middle East and Africa anticipated registering a moderate growth for pigmentation disorders treatment market over the forecast period.

Pigmentation Disorders Treatment Market: Competitive Analysis

The global pigmentation disorder treatment market is highly competitive. The prominent players in the global pigmentation disorders treatment market are Bayer AG, Pierre Fabre Pharmaceuticals, EpiPharm AG, SkinCeuticals International, Galderma laboratories, VIVIERPHARMA, Obagi Cosmeceuticals LLC., La Roche-Posay, and ALLERGAN.